CAARUD: client profiles and practices in 2008
Tendances n° 74, OFDT, 9 p.
The status of CAARUD (Support Centres for the Reduction of Drug-related Harms) has been accessible since 2006 to structures (e.g., "drop-in", needle exchange programmes, street teams and mediation teams) that carry out drug-related harm reduction missions.
French CAARUDs mainly admit drug users who, although they can be followed up by healthcare system services (whether or not specialised in addictology), tend to have, on average, more uncontrolled addiction than users in general and live in more unstable social situations.
In order to acquire monitoring indicators for the characteristics of treated drug users and help improve the responses of professionals and authorities to the changing needs of this population, a biennial national survey of treated drug users was announced by the National Health Directorate (DGS). The survey is called "ENa-CAARUD".
This issue of Tendances presents the main results of the second edition of this survey, which was conducted in 2008.
Authors : Agnès Cadet-Taïrou, Anaëlle Coquelin, Abdalla Toufik
Download the PDF file (490 Ko)
Drugs in Europe
What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2018 EMCDDA European Drug Report.
Country drug reports 2017
Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.